giiant pharma Revenue and Competitors
Estimated Revenue & Valuation
- giiant pharma's estimated annual revenue is currently $465k per year.
- giiant pharma's estimated revenue per employee is $77,500
Employee Data
- giiant pharma has 6 Employees.
- giiant pharma grew their employee count by -14% last year.
giiant pharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
giiant pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $25.9M | 221 | 3% | $150.5M | N/A |
#2 | $34.6M | 223 | -56% | N/A | N/A |
#3 | $1.9M | 12 | 20% | N/A | N/A |
#4 | $4M | 26 | -7% | N/A | N/A |
#5 | $67.9M | 438 | 1% | N/A | N/A |
#6 | $10.9M | 70 | 0% | N/A | N/A |
#7 | $10.9M | 70 | 0% | N/A | N/A |
#8 | $27M | 174 | -22% | N/A | N/A |
#9 | $5.1M | 33 | 14% | N/A | N/A |
#10 | $3.9M | 50 | 16% | $65M | N/A |
What Is giiant pharma?
Giiant is a preclinical-stage biotech company, with its proprietary Precision Delivery technology platform, designs gut-restricted, tissue-specific, small molecule, drug therapeutics with various biological targets in gastroenterology. Its lead program GT-2108 is a microbiota-activated PDE4 inhibitor prodrugs, with improved drug tolerability and enhanced therapeutic effect.
keywords:N/A
N/A
Total Funding
6
Number of Employees
$465k
Revenue (est)
-14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Montreal
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.1M | 6 | -25% | $26.6M |
#2 | $0.9M | 6 | 0% | N/A |
#3 | $0.4M | 6 | N/A | N/A |
#4 | $0.4M | 6 | N/A | N/A |
#5 | $0.4M | 6 | N/A | N/A |